An adduct of cis-diamminedichloroplatinum(II) and poly(ethylene glycol)poly(L-lysine)-succinate: Synthesis and cytotoxic properties

Bioconjugate Chemistry

Volumn 7, Issue 1, 1996, Pages 144-149

  Bogdanov Jr , A A ^a   Martin, C ^a   Bogdanova, A V ^a   Brady, T J ^a   Weissleder, R ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; BIOCOMPATIBILITY; CELL CULTURE; CELL PROLIFERATION; CONTROLLED DRUG DELIVERY; DRUG DOSAGE; ETHYLENE GLYCOL; POLYETHYLENE GLYCOLS; POLYOLS; TARGETED DRUG DELIVERY; TUMORS;

ANTINEOPLASTIC DRUGS; CYTOTOXIC; GRAFT- COPOLYMERS; HALF LIVES; LONG CIRCULATING; NON-COVALENT ADDUCTS; POLY-L-LYSINE; PROPERTY; SUCCINATE SYNTHESIS; Ε-POLY-L-LYSINE; POLY(L LYSINE);

ETHYLENE; POLYETHYLENE GLYCOLS;

ANIMALIA;

EID: 0030062240     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc950089b     Document Type: Article

References (32)

1. Rozencweig, M., Von Hoff, D. D., Slovik, M., et al. (1977) Cis-diamminedichloroplatinum (II), a new anticancer drug. Ann. Intern. Med. 86, 803-812.
2. American Cancer Society textbook of clinical oncology (1991) (A. I. Holleb, D. J. Fink, and G. P. Murphy. Eds.) p 691, American Cancer Society, Inc., Atlanta.
3. Sherman, S. E., and Lippard, S. J. (1987) Structural Aspects of Platinum Anticancer Drug Interactions with DNA. Chem. Rev. 87, 1153-1181.
4. Meyn, R. E., Stephens, L. C., Hunter, N. R., and Milas, L. (1995) Kinetics of cisplatin-induced apoptosis in murine mammary and ovarian adenocarcinomas. Int. J. Cancer 60, 725-729.
5. Muggia, F. M., Rozencweig, M., and Penta, J. (1980) Clinical implications of cisplatin pharmacology. Recent Results Cancer Res. 74, 132-138.
6. Dentino, M., Luft, F. C., Yum, M. N., Williams, S. D., and Einhorn, L. H. (1978) Long-term effect of cis-diamminedichloride platinum (CDDP) on renal function in man. Cancer 41, 1274-1281.
7. Groth, S., Nielson, H., Sorenson, J. B., Christensen, A. B., Pedersen, A. G., and Rorth, M. (1986) Acute and long-term nephrotoxicity of cis-platinum in man. Cancer Chemother. Pharmacol. 17, 191-196.
8. Weiss, R. B., and Christian, M. C. (1993) New cisplatin analogues in development. A review. Drugs 46, 360-377.
9. Noteborn, H. P. J. M., and Verrijk, R. (1989) Drug delivery systems. Curr. Opin. Oncol. 1, 222-230.
10. Schechter, B., Pauzner, R., Arnon, R., and Wilchek, M. (1986) cis-Platinum(II) Complexes of Carboxymethyl-Dextran as Potential Antitumor Agents. I. Preparation and Characterization. Cancer Biochem. Biophys. 8, 277-287.
11. Schechter, B., Pauzner, R., Arnon, R., and Wilchek, M. (1986) cis-Platinum(II) complexes of carboxymethyl-dextran as potential antitumor agents. II. In Vitro and In Vivo Activity. Cancer Biochem. Biophys. 8, 289-298.
12. Schechter, B., Rosing, M. A., Wilchek, M., and Arnon, R. (1989) Blood levels and serum protein binding of cis-Platinum(II) complexed to carboxymethyl-dextran. Cancer Chemother. Pharmacol. 24, 161-166.
13. Schechter, B., Wilchek, M., and Arnon, R. (1987) Increased therapeutic efficacy of cis-platinum complexes of poly-L-glutamic acid against a murine carcinoma. Int. J. Cancer 39, 409-413.
14. Schechter, B., Pauzner, R., Arnon, R., Haimovich, J., and Wilchek, M. (1987) Selective cytotoxicity against tumor cells by cisplatin complexed to antitumor antibodies via carboxymethyl dextran. Cancer Immunol. Immunother. 25, 225-230.
15. Schechter, B., Arnon, R., Wilchek, M., Schlessinger, J., Hurwitz, E., Aboud-Pirak, E., and Sela, M. (1991) Indirect Immunotargeting of cis-Pt to Human Epidermoid Carcinoma KB using the Avidin-Biotin System. Int. J. Cancer 48, 167-172.
16. Arnon, R., Schecter, B., and Wilchek, M. (1991) Complexes and Conjugates of cis-Pt for Immunotargeted Chemotherapy. Adv. Exp. Med. Biol. 303, 79-90.
17. Verrijk, R., Smolders, I. J. H., Bosnie, N., and Begg, A. C. (1992) Reduction of Systemic Exposure and Toxicity of Cisplatin by Encapsulation in Poly-lactide-co-glycolide. Cancer Res. 52, 6653-6656.
18. Splenhauer, G., Vert, M., Benoit, J. P., and Boddaert, A. (1989) In Vitro and In Vivo degradation of poly(D,L-lactide/glycolide) type microspheres made by solvent evaporation method. Biomaterials 10, 557-563.
19. Ike, O. Shimizu, Y., Wada, R., Hyon, S.-H., and Ikada, Y. (1992) Controlled cisplatin delivery system using poly(D,L-lactic acid). Biomaterials 13, 230-234.
20. Yokoyama, M., Okano, T., Sakurai, Y., Ekimoto, H., Shibazaki, C., and Kataoka, K. (1991) Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. Cancer Res. 51, 3229-3236.
21. Yokoyama, M. (1995) Polymeric micelles for drug delivery: their strategy and perspective. Proceedings of 7th International Symposium on Recent Advances in Drug Delivery, pp 99-102, Center for Controlled Chemical Delivery, Salt Lake City, UT.
22. Perez-Soler, R., Lopez-Berestein, G., and Lautersztain, J. (1989) Phase I clinical and pharmacological study of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II). Cancer Res. 50, 4254-4259.
23. Gondal, J. A., Preuss, H. G., Swartz, R., and Rahman, A. (1993) Comparative pharmacological, toxicological and antitumoral evaluation of free and liposome-encapsulated cisplatin in rodents. Eur. J. Cancer 19A, 1536-1542.
24. Yolles, S., Leafe, T. D., and Meyer, F. J. (1975) Timed-Release Depot for Anticancer Agents. J. Pharm. Sci. 64, 115-116
25. Bogdanov, A. A., Jr., Weissleder, R., Frank, H., Bogdanova, A., Noasiff, N., Schaffer, B., Tsai, E., Papisov, M., and Brady, T. J. (1993) A new macromolecule as a contrast agent for MR angiography: preparation, properties and animal studies. Radiology 187, 701-706.
26. Bogdanov, A., Jr., Weissleder, R., Tsai, E., Schaffer, B., Bogdanova, A., Nossiff, N., Papisov, M., and Brady, T. (1993) Tumor neovascularity imaging by contrast-enhanced MR imaging. Proceedings of the Society of Magentic Resonance in Medicine, 12th Meeting, New York, p 577, Society of Magnetic Resonance, Berkeley, CA.
27. Bogdanov, A. A., Jr., Weissleder, R., and Brady, T. J. (1995) Protected angiopolymers for vascular imaging. Handbook of targeted delivery of imaging agents (V. P. Torchilin. Ed.) pp 501-522, CRC Press, Boca Raton, FL.
28. Staros, J. V., Wright, R. W., and Swingle, D. M. (1986) Enhancement by N-hydroxysulfosuccinimide of water-soluble carbodiimide-mediated coupling reactions. Anal. Biochem. 156, 220-222.
29. Baleux, B. (1972) Dosage colorimetrique d'agente de surface non ioniques polyoxyethylenes a l'aide d'une solution iodo-iodaide. C. R. Acad. Sci., Ser. III 274, 1617-1620.
30. Bogdanov, A. A., Jr., Callahan, R. J., Wilkinson, R. A., Martin, C., Cameron, J. A., Fischman, A. J., Brady, T. J., and Weissleder, R. (1994) Synthetic Copolymer Kit for Radionuclide Blood-Pool Imaging. J. Nucl. Med. 35, 1880-1886.
31. Jain, R. K. (1988) Transvascular and interstitial transport in tumors. Vascular endothelium in health and disease (S. Chien, Ed.) pp 215-220, Elsevier, Amsterdam.
32. Jain, R. K. (1989) Delivery of novel therapeutic agents in tumors: physiological barriers and strategies. J. Natl. Cancer Inst. 81, 570-576.